Circuit-to-circuit pharma stock hits upper circuit; here's why
The pharma stock has rewarded its investors with significant gains. The scrip has delivered whopping 51 per cent returns in a month and mulitbagger returns by soaring 333 per cent in a year.
The pharma stock has rewarded its investors with significant gains. The scrip has delivered whopping 51 per cent returns in a month and mulitbagger returns by soaring 333 per cent in a year.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2246892016-591d218bfe1441938adaf2ea2b9cffee.jpg?#)
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
